121 related articles for article (PubMed ID: 35625907)
61. An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges.
Xu X; Chen Y; Lu X; Zhang W; Fang W; Yuan L; Wang X
Biochem Pharmacol; 2022 Nov; 205():115279. PubMed ID: 36209840
[TBL] [Abstract][Full Text] [Related]
62. Integration of the Connectivity Map and Pathway Analysis to Predict Plant Extract's Medicinal Properties-The Study Case of
Gahramanov V; Oz M; Aouizerat T; Rosenzweig T; Gorelick J; Drori E; Salmon-Divon M; Sherman MY; Lubin BCR
Plants (Basel); 2022 Aug; 11(17):. PubMed ID: 36079576
[TBL] [Abstract][Full Text] [Related]
63. In Silico and In Vitro Studies of
Suručić R; Radović Selgrad J; Kundaković-Vasović T; Lazović B; Travar M; Suručić L; Škrbić R
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014415
[TBL] [Abstract][Full Text] [Related]
64. SARS-CoV-2: Origin, Evolution, and Targeting Inhibition.
Ning S; Yu B; Wang Y; Wang F
Front Cell Infect Microbiol; 2021; 11():676451. PubMed ID: 34222046
[TBL] [Abstract][Full Text] [Related]
65. Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs.
Hosseini M; Chen W; Xiao D; Wang C
Precis Clin Med; 2021 Mar; 4(1):1-16. PubMed ID: 33842834
[TBL] [Abstract][Full Text] [Related]
66. Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2.
Jin YH; Lee J; Jeon S; Kim S; Min JS; Kwon S
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625907
[TBL] [Abstract][Full Text] [Related]
67. Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor.
Tan H; Ma C; Wang J
Med Chem Res; 2022; 31(7):1147-1153. PubMed ID: 35578732
[TBL] [Abstract][Full Text] [Related]
68. Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor.
Tan H; Ma C; Wang J
Res Sq; 2022 Mar; ():. PubMed ID: 35378761
[TBL] [Abstract][Full Text] [Related]
69. [Identifying SARS-CoV-2 main protease inhibitors by a novel sandwich-like fluorescence polarization screening assay].
Yan H; Yan G; Qi H; Liu Z; Liu X; Liu X; Li N; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2352-2364. PubMed ID: 35786485
[TBL] [Abstract][Full Text] [Related]
70. Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes.
Sugamoto K; Tanaka YL; Saito A; Goto Y; Nakayama T; Okabayashi T; Kunitake H; Morishita K
Biochem Biophys Res Commun; 2022 Jul; 615():56-62. PubMed ID: 35605406
[TBL] [Abstract][Full Text] [Related]
71. Identification of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
[TBL] [Abstract][Full Text] [Related]
72. Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of
Jin YH; Jeon S; Lee J; Kim S; Jang MS; Park CM; Song JH; Kim HR; Kwon S
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214108
[TBL] [Abstract][Full Text] [Related]
73. An oral SARS-CoV-2 M
Owen DR; Allerton CMN; Anderson AS; Aschenbrenner L; Avery M; Berritt S; Boras B; Cardin RD; Carlo A; Coffman KJ; Dantonio A; Di L; Eng H; Ferre R; Gajiwala KS; Gibson SA; Greasley SE; Hurst BL; Kadar EP; Kalgutkar AS; Lee JC; Lee J; Liu W; Mason SW; Noell S; Novak JJ; Obach RS; Ogilvie K; Patel NC; Pettersson M; Rai DK; Reese MR; Sammons MF; Sathish JG; Singh RSP; Steppan CM; Stewart AE; Tuttle JB; Updyke L; Verhoest PR; Wei L; Yang Q; Zhu Y
Science; 2021 Dec; 374(6575):1586-1593. PubMed ID: 34726479
[TBL] [Abstract][Full Text] [Related]
74. Inhibitory Effects and Surface Plasmon Resonance-Based Binding Affinities of Dietary Hydrolyzable Tannins and Their Gut Microbial Metabolites on SARS-CoV-2 Main Protease.
Li H; Xu F; Liu C; Cai A; Dain JA; Li D; Seeram NP; Cho BP; Ma H
J Agric Food Chem; 2021 Oct; 69(41):12197-12208. PubMed ID: 34586788
[TBL] [Abstract][Full Text] [Related]
75. SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System.
Min JS; Kwon S; Jin YH
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440200
[TBL] [Abstract][Full Text] [Related]
76. Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates.
Wang Y; Fang S; Wu Y; Cheng X; Zhang LK; Shen XR; Li SQ; Xu JR; Shang WJ; Gao ZB; Xia BQ
Acta Pharmacol Sin; 2022 Apr; 43(4):781-787. PubMed ID: 34294887
[TBL] [Abstract][Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
